Skip to navigation Skip to main content
Oncology Nurse Advisor
  • Cancer Types
    • Cancer Types
      • Brain Cancer
      • Breast Cancer
      • Cervical Cancer
      • Chronic Myeloid Leukemia‎
      • Colorectal Cancer
      • Gastrointestinal Cancer
      • General Oncology
      • Genitourinary Cancer
      • Gynecologic Cancer
      • Head and Neck Cancer
      • Hematologic Cancers
      • Kidney Cancer
      • Leukemia
      • Liver Cancer
      • Lung Cancer
      • Lymphoma
      • Melanoma
      • Multiple Myeloma
      • Myeloproliferative Neoplasms
      • Ovarian Cancer
      • Pancreatic Cancer
      • Prostate Cancer
      • Sarcoma
      • Skin Cancer
  • Hot Topics
    • Hot Topics
      • Advisor Forum
      • Ask a Pharmacist
      • Ask the Experts
      • Communication Challenges
      • Complementary and Alternative Medicine
      • From CancerCare
      • General Medicine
      • Issues in Cancer Survivorship
      • Journal Review
      • Navigation
      • Oncology Nursing
      • Radiation and Your Patient
      • Reflections
      • Side-Effect Management
      • Stat Consult
      • The Patient’s Voice
      • The Total Patient
  • Regimens
  • Resources
    • Resources

      Clinical Tools

      • Clinical Charts
      • Drug Information Database
      • Medical Calculators

      Professional Resources

      • Expert Perspective
      • Digital Issues
      • Job Board
      • Product Directory
      • Useful Links
  • For Patients
    • For Patients
      • Advocacy
      • Cancer Support Groups
      • Fact Sheets
      • Finding Clinical Trials
  • Conferences
    • Conferences

      Oncology Conferences

      • Conference Coverage

      News Resources

      • Daily Oncology News
      • Web Exclusives
  • ONA Summit
  • News
  • CE
  • Fact Sheets
  • Publishers Alliance
  • Navigation
  • Expert Perspective
  • Slideshows
  • Jobs

Home » Headlines

Publish Date September 22, 2015

Prevention, treatment of invasive fungal disease in allogeneic stem-cell transplantation recipients

  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Reddit
  • Print
  • Share by Email

the Oncology Nurse Advisor take:

A team of researchers from Shanghai, China, hypothesized that prophylactic therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF) decreases invasive fungal disease (IFD) in patients undergoing allogeneic hematopoietic stem-cell transplantation (alloHSCT).

They compared once-daily subcutaneous GM-CSF (5 to 7 µg/kg per day), granulocyte colony-stimulating factor (G-CSF; 5 to 7 µg/kg per day), or a combination of G-CSF and GM-CSF (2 to 3 µg/kg per day each).

They randomly assigned 206 patients undergoing alloHSCT to one of the three treatments, which were started on day 5 after transplantation. Treatment was continued until the absolute neutrophil count was ≥1.5x109/L for 2 consecutive days.

The results showed no significant difference in 100-day incidences of proven and probable IFD among the three groups. In the GM-CSF and G-CSF+GM-CSF groups, 100-day cumulative mortality after transplantation and 100-day transplantation-related mortality were lower than in the G-CSF group.

IFD-related mortality was also lower in the GM-CSF and G-CSF+GM-CSF groups after 600 days follow-up, compared with the G-CSF group.

The researchers conclude that prophylactic GM-CSF improves 100-day transplantation-related mortality, 100-day cumulative mortality, and 600-day IFD-related mortality in recipients of alloHSCT, compared with G-CSF.

Mutated genes in leukemia can reprogram blood stem cells, affecting blood cell production.
Prophylactic therapy with granulocyte-macrophage colony-stimulating factor may decrease invasive fungal disease.

Liping Wan and Chun Wang, Shanghai Jiao Tong University Affiliated First People’s Hospital, Shanghai; Yicheng Zhang and Jianfeng Zhou, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan; Yongrong Lai and Zhongming Zhang, First Affiliated Hospital of Guangxi Medical University, Nanning; Ming Jiang and Xianlin Duan, Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi; Yongping Song and Yuewen Fu, Henan Cancer Hospital, Zhengzhou; and Lianming Liao, Fujian Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China.

READ FULL ARTICLE Curated publisher From Ascopubs

Topics:

Hematologic Cancers
  • Loading...

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next post in Headlines

Fatigue Prognostic for Survival in Certain Patients With Myelodysplastic Syndromes

Back to Top
  • Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community online and in print. Daily online exclusives cover late breaking oncology news, safe handling and administration of chemotherapy drugs, side effect management, and new developments in specific cancers.

  • Resources
    • Editorial Board
    • Subscribe
    • Author Guidelines
    • Permissions
    • Reprints
  • User Center
    • About Us
    • Contact Us
    • Advertise
  • Other Haymarket Medical Websites
    • Cancer Therapy Advisor
    • Clinical Advisor
    • Clinical Pain Advisor
    • Dermatology Advisor
    • Endocrinology Advisor
    • Gastroenterology Advisor
    • Hematology Advisor
    • Infectious Disease Advisor
    • McKnight’s Long Term Care News
    • McKnight’s Senior Living
    • Medical Bag
    • MPR
    • myCME
    • Neurology Advisor
    • Ophthalmology Advisor
    • Optometry Advisor
    • Psychiatry Advisor
    • Pulmonology Advisor
    • Rare Disease Advisor
    • Renal and Urology News
    • Rheumatology Advisor
    • The Cardiology Advisor
  • Copyright © 2023 Haymarket Media, Inc. All Rights Reserved
    This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
    Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.

Loading...
Loading...
Loading...
Loading...